Lineage Cell Therapeutics, Inc. Conversion of Stock, Shares Issued
Lineage Cell Therapeutics, Inc. (LCTX) reported Conversion of Stock, Shares Issued of 625.00 thousand shares for the 0-month period ending 2017-02-17, per its 10-K filed 2019-03-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2019-03-14
- 2017-02-17: Conversion of Stock, Shares Issued 0 month 625.00K shares.
| Period end | Conversion of Stock, Shares Issued 0 month |
|---|---|
| 2017-02-17 | 625.00K shares 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |